Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-14T16:01:02.809Z Has data issue: false hasContentIssue false

Differences in gut microbiota composition in metabolic syndrome and type 2 diabetes subjects in a multi-ethnic population: the HELIUS study

Published online by Cambridge University Press:  10 June 2020

Mélanie Deschasaux
Affiliation:
Department of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Center, Amsterdam, Netherlands
Kristien Bouter
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Andrei Prodan
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Evgeni Levin
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Albert Groen
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Hilde Herrema
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Valentina Tremaroli
Affiliation:
Wallenberg Laboratory, Sahlgrenska Hospital, University of Gothenburg, Gothenburg, Sweden
Marieke Snijder
Affiliation:
Department of Public Health, Amsterdam University Medical Center, Amsterdam, Netherlands
Mary Nicolaou
Affiliation:
Department of Public Health, Amsterdam University Medical Center, Amsterdam, Netherlands
Aeilko Zwinderman
Affiliation:
Department of Clinical Epidemiology and Biostatistics, Amsterdam University Medical Center, Amsterdam, Netherlands
Fredrik Bäckhed
Affiliation:
Wallenberg Laboratory, Sahlgrenska Hospital, University of Gothenburg, Gothenburg, Sweden
Max Nieuwdorp
Affiliation:
Department of Internal and Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Recently, increased attention has been drawn to the composition of the intestinal microbiota and its possible role in metabolic syndrome and type 2 diabetes (T2DM). However, potential variation in gut microbiota composition across ethnic groups is rarely considered despite observed unequal prevalence for these diseases. Our objective was therefore to study the gut microbiota composition across health, metabolic syndrome and T2DM in a multi-ethnic population residing in the same geographical area. 16S rRNA gene sequencing was performed on fecal samples from 3926 participants to the HELIUS cohort (Amsterdam, The Netherlands), representing 6 ethnic groups (Dutch, Ghanaians, Moroccans, Turks, Surinamese of either African or South-Asian descent). Included participants completed a questionnaire and underwent a physical examination and overnight fasted blood sampling. Gut microbiota composition was compared across metabolic status (diabetes with and without metformin use, metabolic syndrome and its subsequent components, health) and ethnicities using Wilcoxon-Mann-Withney tests and logistic regressions. Overall, the gut microbiota alpha-diversity (richness, Shannon index and phylogenetic diversity) decreased with worsening of the metabolic state (comparing health to metabolic syndrome to T2DM) but this was only partially reproduced in ethnic-specific analyses. In line, a lower alpha-diversity was found in relation to all metabolic syndrome components as well as in T2DM subjects using metformin compared to non-users. Alterations, mainly decreased abundances, were also observed at the genus level (many Clostridiales) in metabolic syndrome subjects and more strongly in T2DM subjects with differences across ethnic groups. In particular, we observed decreased abundances of members of the Peptostreptococcaceae family and of Turicibacter and an increased abundance of a member of the Enterobacteriaceae family. Our data highlight several compositional differences in the gut microbiota of individuals with metabolic syndrome or T2DM. These features, confirming prior observations, give some insights into potential key intestinal bacteria related to a worsening of metabolic state. Our results also underscore possible ethnic-specific profiles associated with these microbiota alterations that should be further explored.

Type
Abstract
Copyright
Copyright © The Authors 2020